Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
15.40
-0.18 (-1.16%)
At close: Aug 1, 2025, 4:00 PM
15.70
+0.30 (1.95%)
After-hours: Aug 1, 2025, 7:36 PM EDT

Tandem Diabetes Care Stock Forecast

Stock Price Forecast

The 13 analysts that cover Tandem Diabetes Care stock have a consensus rating of "Buy" and an average price target of $32.15, which forecasts a 108.77% increase in the stock price over the next year. The lowest target is $14 and the highest is $59.

Price Target: $32.15 (+108.77%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$14$32.15$24$59
Change-9.09%+108.77%+55.84%+283.12%

Analyst Ratings

The average analyst rating for Tandem Diabetes Care stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy444222
Buy665444
Hold566766
Sell000000
Strong Sell000011
Total151615131313

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Citigroup
Citigroup
Strong Sell
Downgrades
$24$14
Strong SellDowngrades$24$14-9.09%Jul 9, 2025
Truist Securities
Truist Securities
Hold
Initiates
$24
HoldInitiates$24+55.84%Jun 16, 2025
Citigroup
Citigroup
Hold
Maintains
$20$24
HoldMaintains$20$24+55.84%May 22, 2025
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$58$59
Strong BuyMaintains$58$59+283.12%May 1, 2025
Stifel
Stifel
Strong Buy
Maintains
$60$31
Strong BuyMaintains$60$31+101.30%May 1, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
1.02B
from 940.20M
Increased by 8.91%
Revenue Next Year
1.14B
from 1.02B
Increased by 10.94%
EPS This Year
-1.44
from -1.47
EPS Next Year
-0.70
from -1.44
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
498.83M702.80M801.22M747.72M940.20M1.02B1.14B1.25B
Revenue Growth
37.68%40.89%14.00%-6.68%25.74%8.91%10.94%9.60%
EPS
-0.560.24-1.47-3.43-1.47-1.44-0.70-0.03
EPS Growth
--------
Forward PE
--------
No. Analysts
-----272720
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High1.1B1.3B1.4B
Avg1.0B1.1B1.2B
Low975.4M1.0B1.1B

Revenue Growth

Revenue Growth20252026202720282029
High
14.5%
24.1%
23.7%
Avg
8.9%
10.9%
9.6%
Low
3.7%
1.5%
-2.3%

EPS Forecast

EPS20252026202720282029
High-1.17-0.260.96
Avg-1.44-0.70-0.03
Low-1.65-1.38-0.74

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.